Go to Pathways list
Support our work
DONATE NOW

Beyond PARP inhibition: pathways of potential clinical relevance and targeted treatments in ovarian cancer

E-session 521
Add to My Agenda

Expert:

Ilaria Colombo, expert of session 'Beyond PARP  inhibition: pathways  of potential  clinical relevance and targeted treatments in ovarian cancer'

Ilaria Colombo
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland

Discussant:

Anastasios Stathis, expert of session 'Beyond PARP  inhibition: pathways  of potential  clinical relevance and targeted treatments in ovarian cancer'

Anastasios Stathis
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland

Share on:

This session is part of the following pathway(s):

GYNAECOLOGY: Ovarian cancer

02
Apr 2020
18:15-19:00 CEST

Top